KRAS, HRAS, and NRAS are oncogenes that are frequently mutated human cancers [8], with KRAS mutations being the most prevalent, forming 85% of all RAS mutations and affecting about 13% of cancer patients [9]. This evidence concerns the gene KRAS and cancer.